Details for Patent: 10,058,614
Which drugs does patent 10,058,614 protect, and when does it expire?
Patent 10,058,614 protects SYMBRAVO and is included in one NDA.
This patent has two hundred and twenty-nine patent family members in thirty-two countries.
Summary for Patent: 10,058,614
| Title: | Pharmaceutical compositions comprising meloxicam |
| Abstract: | Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain. |
| Inventor(s): | Herriot Tabuteau |
| Assignee: | Axsome Therapeutics Inc |
| Application Number: | US15/797,955 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,058,614 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 10,058,614
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Axsome | SYMBRAVO | meloxicam; rizatriptan benzoate | TABLET;ORAL | 215431-001 | Jan 30, 2025 | RX | Yes | Yes | 10,058,614 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,058,614
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016218992 | ⤷ Start Trial | |||
| Australia | 2018205790 | ⤷ Start Trial | |||
| Australia | 2018265411 | ⤷ Start Trial | |||
| Australia | 2019203328 | ⤷ Start Trial | |||
| Australia | 2019297360 | ⤷ Start Trial | |||
| Australia | 2020205306 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
